Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammation | 3 | 2017 | 618 | 0.700 |
Why?
|
| Interleukin-15 | 2 | 2017 | 13 | 0.610 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 119 | 0.550 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 127 | 0.540 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 251 | 0.540 |
Why?
|
| Penile Neoplasms | 3 | 2021 | 14 | 0.480 |
Why?
|
| Cell Movement | 1 | 2017 | 571 | 0.450 |
Why?
|
| Prostatic Neoplasms | 4 | 2017 | 935 | 0.450 |
Why?
|
| Cystitis | 2 | 2008 | 8 | 0.390 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 336 | 0.370 |
Why?
|
| Receptors, Nicotinic | 2 | 2008 | 106 | 0.360 |
Why?
|
| Dermis | 1 | 2009 | 8 | 0.360 |
Why?
|
| Epithelium | 1 | 2009 | 79 | 0.350 |
Why?
|
| Wound Healing | 1 | 2009 | 70 | 0.330 |
Why?
|
| Urinary Bladder | 2 | 2009 | 29 | 0.330 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 197 | 0.310 |
Why?
|
| Estradiol | 1 | 2007 | 262 | 0.270 |
Why?
|
| Cervix Uteri | 2 | 2023 | 42 | 0.260 |
Why?
|
| Mice | 8 | 2020 | 5913 | 0.210 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1015 | 0.210 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 803 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 1609 | 0.190 |
Why?
|
| Piperidones | 1 | 2019 | 9 | 0.180 |
Why?
|
| Chalcones | 1 | 2019 | 14 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2020 | 95 | 0.170 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2018 | 11 | 0.170 |
Why?
|
| Mice, SCID | 2 | 2017 | 150 | 0.170 |
Why?
|
| Neoplasm Seeding | 1 | 2018 | 5 | 0.160 |
Why?
|
| Vitreous Body | 1 | 2018 | 11 | 0.160 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 16 | 0.160 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 11 | 0.160 |
Why?
|
| Retinoblastoma | 1 | 2018 | 16 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 178 | 0.160 |
Why?
|
| Metabolomics | 1 | 2018 | 81 | 0.160 |
Why?
|
| Receptors, Androgen | 2 | 2017 | 126 | 0.160 |
Why?
|
| Cyclophosphamide | 2 | 2008 | 54 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2018 | 127 | 0.150 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 40 | 0.150 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2017 | 16 | 0.150 |
Why?
|
| Animals | 8 | 2020 | 15081 | 0.140 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 118 | 0.140 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 175 | 0.130 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 2231 | 0.130 |
Why?
|
| Prostate | 1 | 2017 | 154 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2018 | 277 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 352 | 0.120 |
Why?
|
| Mouth Diseases | 1 | 2014 | 6 | 0.120 |
Why?
|
| Alphapapillomavirus | 1 | 2014 | 38 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2010 | 24 | 0.110 |
Why?
|
| Humans | 13 | 2023 | 37093 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2018 | 1908 | 0.110 |
Why?
|
| Methionine | 1 | 2011 | 30 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 441 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 807 | 0.100 |
Why?
|
| Male | 8 | 2021 | 20025 | 0.100 |
Why?
|
| Granulation Tissue | 1 | 2009 | 1 | 0.090 |
Why?
|
| Integrases | 1 | 2009 | 26 | 0.090 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2009 | 3 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 105 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 93 | 0.090 |
Why?
|
| Neoplasms | 1 | 2019 | 1103 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2009 | 110 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 187 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 81 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 172 | 0.080 |
Why?
|
| Actins | 1 | 2009 | 148 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 115 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 601 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 252 | 0.080 |
Why?
|
| Puerto Rico | 3 | 2023 | 1378 | 0.080 |
Why?
|
| Protamines | 1 | 2008 | 18 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 1371 | 0.080 |
Why?
|
| Mecamylamine | 1 | 2007 | 15 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 19 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 128 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 893 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 539 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2009 | 933 | 0.070 |
Why?
|
| Middle Aged | 6 | 2021 | 10129 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 251 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2007 | 366 | 0.070 |
Why?
|
| Prognosis | 2 | 2021 | 739 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1130 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 171 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 1455 | 0.050 |
Why?
|
| Female | 4 | 2023 | 20969 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 10 | 0.050 |
Why?
|
| Disease Management | 1 | 2021 | 61 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 97 | 0.050 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 67 | 0.050 |
Why?
|
| Bacteria | 1 | 2023 | 255 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2020 | 29 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 275 | 0.040 |
Why?
|
| ROC Curve | 2 | 2011 | 138 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 72 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 6741 | 0.040 |
Why?
|
| Eye Enucleation | 1 | 2018 | 3 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 293 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 409 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 11712 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Pregnancy | 1 | 2023 | 1549 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 122 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 142 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 325 | 0.040 |
Why?
|
| Azoxymethane | 1 | 2017 | 7 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 502 | 0.040 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 12 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 399 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 448 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 448 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 202 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 269 | 0.030 |
Why?
|
| Carcinogens | 1 | 2017 | 124 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 1354 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 859 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 1095 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2018 | 339 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 188 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 617 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2379 | 0.030 |
Why?
|
| Risk Factors | 2 | 2014 | 3562 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 49 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 2026 | 0.030 |
Why?
|
| Age Distribution | 1 | 2012 | 225 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2014 | 164 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 730 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 131 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2010 | 17 | 0.020 |
Why?
|
| Genes, myc | 1 | 2010 | 29 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 22 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2010 | 35 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1033 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 49 | 0.020 |
Why?
|
| Sexual Partners | 1 | 2014 | 314 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 48 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 219 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 441 | 0.020 |
Why?
|
| Chemokine CCL4 | 1 | 2008 | 19 | 0.020 |
Why?
|
| Chemokine CX3CL1 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2008 | 88 | 0.020 |
Why?
|
| Fibrosis | 1 | 2009 | 159 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1067 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2008 | 63 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 923 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 515 | 0.020 |
Why?
|
| Acute Disease | 1 | 2008 | 147 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 562 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 940 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2721 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 681 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 4268 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 5363 | 0.010 |
Why?
|
| United States | 1 | 2012 | 4223 | 0.010 |
Why?
|
| HIV Infections | 1 | 2014 | 2303 | 0.010 |
Why?
|
Martinez-Ferrer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_